This job has expired

You will need to login before you can apply for a job.

Site Head, Facilities Operations (Waltham)

Intellia Therapeutics
Waltham, MA
Start date
Aug 10, 2022
You need to sign in or create an account to save a job.

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How you will Achieve More with Intellia:

Intellia is opening a 170,000 square foot state-of-the-art GMP manufacturing facility in Waltham, MA and we are looking for a Senior Director to serve as our Site Head of Facilities Operations. This building will house office and lab space, including both cGMP and non-cGMP labs. This newly created role reports to the Vice President of Facilities Operations and EH&S. If you have prior experience supporting cGMP facilities operations and engineering as it relates to specific MEP and BMS infrastructure and systems management, this could be the role for you! Some of the daily responsibilities of this role include:

  • Manage the Facilities Operation Department and third-party contractors supporting the office and non-cGMP lab space within the Intellia leased space

  • Manage all core building infrastructure as it relates to MEPs, BMS, and other building related systems

  • Assist the VP of Facilities Operation and EH&S with the design and construction of the Waltham facility as required

  • Manage city, state, and federal regulations associated with the building classification and use

  • Act as the Intellia liaison with Real Estate/Property Management company for all building related activities, procedures, and protocols

  • Support and work strategically with Waltham’s Technical Operation organization

  • Manage budgets pertaining to the site including rent, utilities, and operating expenses

  • Partner strategically with various functional areas within the Facilities Operations and EH&S organization including Security, Lab Operations, Shipping & Receiving and Internal Logistics, and Office Management

About You:

Our ideal candidate will bring 10-15 years of experience working in the Biotechnology industry, 5-10 years of direct construction experience in the Biotechnology industry. Comprehensive knowledge of cGMP requirements and a proven ability to manage multiple functions within a Facilities Operations organization are also required. If you enjoy bringing creativity to a fast-paced environment and have strong problem-solving and team-building skills, we encourage you to apply!


Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.


Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA


Find Us
(857) 285-6200
40 Erie Street
United States
You need to sign in or create an account to save a job.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert